Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension.
Rodney S TaylorAnthony BentleyKaylie MetcalfeMelvin D LoboAjay J KirtaneMichel AziziChristopher ClarkKieran MurphyJennifer H BoerMarjolijn van KeepAn Thu TaNeil C BarmanGarrett SchwabRon AkehurstRoland E SchmiederPublished in: PharmacoEconomics - open (2024)
Endovascular ultrasound RDN with the Paradise system offers patients with rHTN, clinicians, and healthcare systems a cost-effective treatment option alongside antihypertensive medication.